b'
Last year, a team of McMaster researchers made headlines with their invention which allows vaccines to be stored safely and affordably for weeks at a time at temperatures up to 40C.
\\nNow, Carlos Filipe, co-author of the research paper is part of a five-person startup company called Elarex Inc. bringing this technology to market, opening the doors for life-saving anti-viral vaccines to reach remote and impoverished parts of the world. He is also the chair of Chemical Engineering at McMaster University.
\\nResearch Engineer Sahar Esmaeili Samani also shares her journey from graduate student to starting her work with Elarex in March 2020, right when the pandemic hit.
\\nInterviewed by: John Preston
\\nProduced by: Jessie Park
\\nEdited by: Jin Lee and Dan Kim
\\nFollow us on Twitter and Instagram @mcmastereng. Read more at www.eng.mcmaster.ca/news.
'